Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis

Autor: Eckold, C, Kumar, V, Weiner, J, Alisjahbana, B, Riza, A-L, Ronacher, K, Coronel, J, Kerry-Barnard, S, Malherbe, ST, Kleynhans, L, Stanley, K, Soeroto, A, Permana, H, Imaculata, S, Apriani, L, Ugarte-Gil, C, Walzl, G, van Crevel, R, Wijmenga, C, Critchley, JA, Dockrell, HM, Haks, M, Cliff, JM, Malherbe, S, Dockrell, H, Cliff, J, Moore, D, Griffiths, U, Laurence, Y, Aarnouste, R, Netea, M, Ruesen, C, Lachmandas, E, Kaufmann, S, Beigier, M, Golinski, R, Joosten, S, Ottenhoff, T, Vrieling, F, Smith, B, van der Spuy, G, Loxton, A, Chegou, N, Bosman, M, Thiart, L, Nitu, F, Wagman, C, Editoiu, C, Tshivhula, H, Selamolela, M, Prins, N, du Plessis, W, van Rensburg, I, du Toit, L, Critchley, J, Bazavan, I, Pearson, F, Grint, D, Florescu, A, McAllister, S, Hill, P, Verrall, A, Ioana, M, Riza, A, Cioboata, R, Dudau, M, Olteanu, M, Mota, M, Popa, SG, Firanescu, A, Popa, A, Gheonea, I, Bicuti, S, Lepadat, A, Capitanescu, I, Vladu, I, Papurica, M, Clenciu, D, Bicu, M, Streba, C, Demetrian, A, Ciurea, M, Cimpoeru, A, Ciocoiu, A, Dorobantu, S, Olaru, M, Plesea, R, Popescu, EL, Valutanu, I, Cucu, M, Streata, I, Burada, F, Serban-Sosoi, S, Panduru, N, Nicoli, E, Ciontea, M, Tataru, T, Dubreu, V, Stamatoiu, L, Lopez, S, Gunawan, Y, Limascca, R, Ruslami, R, Villaizan, K, Castro, B, Flores, J, Solano, W, Soetedjo, N, Santoso, P, Dewi, N, Chaidir, L, Koesoemadinata, R, Susilawati, N, Annisa, J, Livia, R, Yunivita, V
Přispěvatelé: TANDEM (Concurrent Tuberculosis and Diabetes Mellitus, unraveling the causal link, and improving care) Consortium
Rok vydání: 2021
Předmět:
0301 basic medicine
Microbiology (medical)
Tuberculosis
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
Inflammation
Transcriptome
03 medical and health sciences
chemistry.chemical_compound
South Africa
0302 clinical medicine
Immune system
Diabetes mellitus
Peru
Diabetes Mellitus
Medicine
Humans
030212 general & internal medicine
Articles and Commentaries
Tuberculosis
Pulmonary

Whole blood
diabetes
business.industry
Mycobacterium tuberculosis
medicine.disease
Comorbidity
3. Good health
030104 developmental biology
Infectious Diseases
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
AcademicSubjects/MED00290
chemistry
tuberculosis
inflammation
Indonesia
Hyperglycemia
Immunology
hyperglycemia
Glycated hemoglobin
medicine.symptom
business
Zdroj: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 72, 1, pp. 69-78
Clinical Infectious Diseases
Clinical Infectious Diseases, 72, 69-78
ISSN: 1058-4838
DOI: 10.1093/cid/ciaa751
Popis: Background People with diabetes have an increased risk of developing active tuberculosis (TB) and are more likely to have poor TB-treatment outcomes, which may impact on control of TB as the prevalence of diabetes is increasing worldwide. Blood transcriptomes are altered in patients with active TB relative to healthy individuals. The effects of diabetes and intermediate hyperglycemia (IH) on this transcriptomic signature were investigated to enhance understanding of immunological susceptibility in diabetes-TB comorbidity. Methods Whole blood samples were collected from active TB patients with diabetes (glycated hemoglobin [HbA1c] ≥6.5%) or IH (HbA1c = 5.7% to
Our study shows that people with diabetes and tuberculosis have altered peripheral immune profiles compared to people with only tuberculosis, and that these differences also exist in patients with intermediate hyperglycemia.
Databáze: OpenAIRE